アクセス数 : ?
ダウンロード数 : ?
ID 114198
著者
Nishiyama, Seiichi Shikoku Central Hospital
Abe, Toshio Shikoku Central Hospital
資料タイプ
学術雑誌論文
抄録
A Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by thrombembolic events including thromboembolism (VTE) in association with the presence of antiphospholipid antibodies. The standard treatment of VTE historically consists of anticoagulation therapy with warfarin, a vitamin K antagonist. Recently, direct oral anticoagulants, including rivaroxaban have become available for the treatment of VTE. However, the choice of anticoagulant, and the duration of anticoagulation in patients with APS has not been determined yet due to lack of evidence. Here, we report a case of recurrent venous thrombosis after discontinuation of rivaroxaban therapy and avoiding sedentary life style in a patient with APS. We suggest that indefinite anticoagulation therapy might be needed even in low risk APS cases.
掲載誌名
BMJ Case Reports
ISSN
1757790X
cat書誌ID
AA12533286
出版者
BMJ Publishing Group
12
1
開始ページ
e227663
発行日
2019-01-10
権利情報
This article has been accepted for publication in BMJ Case Reports, 2019 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/bcr-2018-227663.
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
著者版
部局
医学系